Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.
about
Sustained atrial fibrillation after dobutamine stress echocardiography in an older patient with left atrial enlargementSyncope caused by cardiac asystole during dobutamine stress echocardiography.Physical stress testing of bovine jugular veins using magnetic resonance imaging, echocardiography and electrical velocimetry.Evaluating coronary artery disease noninvasively--which test for whom?Comparative ability of dobutamine and exercise stress in inducing myocardial ischaemia in active patientsFunctional MRI in ischemic heart disease based on detection of contraction abnormalities.Current status of stress echocardiography.Feasibility of physiologist-led stress echocardiography for the assessment of coronary artery disease.Prognostic implications of myocardial contractile reserve in patients with ischemic cardiomyopathy.Diagnostic and prognostic use of stress echocardiography in stable patients.Reversible left ventricular dysfunction.Stress Echocardiography: A Review of the Principles and Practice.Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC).Target heart rate to determine the normal value of coronary flow reserve during dobutamine stress echocardiographyThe effects of early administration of atropine during dobutamine stress echocardiography: advantages and disadvantages of early dobutamine-atropine protocol.Stress echocardiographic assessment of mitral valve function repaired using rough-zone trimmingSelection of the optimal stress test for the diagnosis of coronary artery disease.Myocardial perfusion scintigraphy: the evidence.MR imaging assessment of cardiac function.Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography.Dobutamine cardiovascular magnetic resonance: a review.Stress echocardiography: safety and tolerability.Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC).Death caused by splenic artery aneurysm rupture during dobutamine-atropine stress echocardiography: case report and literature review.Dobutamine Stress Echocardiography Safety in Chagas Disease Patients.Myocardial perfusion imaging by computed tomography: today and tomorrow.Intracranial hemorrhage as a complication of dobutamine stress echocardiography: case report and review of the literature.Intraparenchymal haemorrhage and uncal herniation resulting from dobutamine stress echocardiography.Update on new technologies in pediatric echocardiographyIs dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy?Noninvasive evaluation of coronary artery disease: magnetic resonance imaging & multi-slice computed tomography.Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery.What is the current status of quantification and nuclear medicine in cardiology?The use of dobutamine stress echocardiography for the determination of myocardial viability.Complications of pharmacologic stress echocardiography in coronary artery disease.Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.A consideration of current clinical options for stress imaging in the diagnosis and evaluation of coronary artery disease.Acute myocardial infarction in a patient during dobutamine stress echocardiography.Pharmacologic stress echocardiography.Accelerated dobutamine stress testing: safety and feasibility in patients with known or suspected coronary artery disease.
P2860
Q28368084-03CCEB64-22B0-4D8B-8739-E8AFA4ABFA1EQ33174841-81BEECDC-1D28-4E74-B12E-824AA542BF0DQ33579819-D72BD75A-5DAF-47B6-A54B-02FADB0B1090Q33607917-BAF2F8A4-81A9-4098-8209-719E98C888BCQ33613753-446BFC15-8D34-4565-9609-0DE55F70D015Q33744695-C1BA9CF7-B07C-4D86-81C3-A15717593E09Q33890674-CC4B648E-8848-40C1-A3AF-01CF1A474205Q33904185-072BFE9D-B14A-4D71-B4B6-A35A0673706DQ34026372-D3F7078F-770A-4607-A1B4-01E76167B571Q34026473-B18DA820-DAE5-4E1B-BC97-26CFE523B847Q34026485-BD4D6F1C-AA21-4678-867A-2C80593C738FQ34139178-88756F17-B057-477B-B996-743010F9D58DQ34600099-79C9F3D5-7BAF-47DF-B87C-787EB4A4BBB2Q34832382-EB92821D-34FA-4786-817E-D7933A8F8091Q34883485-F94CDEDD-6ED6-43BB-8B2C-6A5FA3E3DC35Q35154163-497C3CF7-34B1-40F1-A67C-73602B35DEB8Q35368991-7B509812-80FD-46B3-91EF-6EF447AA051BQ35765832-67AA0650-95CD-4C2E-B200-927171C05130Q35788369-8A74DA5D-8054-4D93-802D-231B0A0D068EQ36389320-3B911D64-96AC-4EE9-B51D-F24FE0B3FEB9Q36558063-79A4843C-ACD2-4D12-A859-258AB0D3CC74Q37152877-3ABF796D-B726-4145-92A5-9F15CB7E8258Q37200102-77005469-E4BD-47C1-9DB5-1FDE74F29EC0Q37363216-90A6142B-E9AC-4071-B985-BDA6AC14C949Q37691731-A6F482CD-5ED9-4A1D-91B8-B9E4C669BCEFQ37946977-14FD7598-AFEC-43C9-8EF5-AF7A7E1B074AQ38005776-817C4BF9-1EF8-49CB-839D-D7BEC4ABC6BFQ38412652-232DA5ED-4589-4742-9D6C-3BC7DA10D8E6Q38475966-FCC8158A-4917-40E7-B64B-1A669A375246Q38949814-0BE1255D-9AC3-4A7A-AAC4-58CB9CC97321Q40457862-F1E43745-9D42-4026-AA2A-DB5D576CB0BBQ40610977-DE058709-D1C4-4934-8B10-D5910BEAB8F5Q41004706-96409AEC-60F3-4B85-AA41-7EDBF810229EQ41157715-0D67E19C-5FCB-49D4-9655-1A223070AEB7Q41192665-FF20DCEE-AFB9-493C-BF78-28E2DD0BB715Q41675614-DC3AD32B-3639-46E2-A314-F0DCDB44E114Q41675758-140121C1-DFA7-4514-861F-6EFB2259B3BBQ42548221-7F1075C5-856D-4737-A89F-AC59F68FCE3DQ42574522-194E9B30-19D6-41CA-AEA5-00BC00407E83Q43532042-683FC09D-5816-4072-B230-3C99A7B57E5B
P2860
Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Symptoms, adverse effects, and ...... . Experience in 1118 patients.
@en
Symptoms, adverse effects, and ...... . Experience in 1118 patients.
@nl
type
label
Symptoms, adverse effects, and ...... . Experience in 1118 patients.
@en
Symptoms, adverse effects, and ...... . Experience in 1118 patients.
@nl
prefLabel
Symptoms, adverse effects, and ...... . Experience in 1118 patients.
@en
Symptoms, adverse effects, and ...... . Experience in 1118 patients.
@nl
P2093
P356
P1433
P1476
Symptoms, adverse effects, and ...... . Experience in 1118 patients.
@en
P2093
Feigenbaum H
P356
10.1161/01.CIR.88.1.15
P407
P577
1993-07-01T00:00:00Z